Search results:
General Information
- Evidence
- Gene
- mRNA
- CDS
- Protein
- PTM
- Enzyme
- PPi
- Pathway
- Structural
- Domain
- Ontology
- SNP
- Drug
- External Links
Evidence Information
| Pubmed ID | Year | Sample Information | Techniques | Mechanism | Fold Change | Remark |
|---|---|---|---|---|---|---|
| 26362504    | 2015 | Cell line : - Source : - Sample Type : CRC tumor and normal tissue No. of Sample : 50 colorectal cancer patients Stage : - | RT-PCR,RNA interference,Transwell invasion assay,Immunohistochemistry ,Western blotting | Mutation | - | In colorectal adenocarcinomas, p53 mutation correlated with high NF-?B, Fascin and low E-cadherin expression. |
| 25945089    | 2015 | Cell line : - Source : Adnan Menderes University Hospital, Aydin, Turkey Sample Type : CRC Tumor and adjescent tissue No. of Sample : 457 Stage : Duke Stage A-C | Immunohistochemistry | Up-regulation | - | NF-?B, p53, and Ki-67 expressions were significantly higher in the metastatic lymph nodes compared to the primary tumor tissues . |
| 25973304    | 2015 | Cell line : RKO, HT 29, DLD1, LOVO, HCT116, SW480, SW620 Source : Chinese PLA General Hospital. Sample Type : CRC Tumor No. of Sample : 102 Stage : TNM Stage I-IV | real time RT-PCR, methylation specific PCR, Flow cytometry and western blotting | Up-regulation | - | BCL6B suppresses colorectal cancer growth by activating P53 signaling. |
| 9539318    | 1998 | Cell line : HCT116 Source : - Sample Type : - No. of Sample : - Stage : Duke Stage B,C,D. | ELISA | Up-regulation | - | Mutant p53 protein might be used as a potential biomarker in the management of patients with colorectal cancer. Serum levels of the mutant p53 protein in patients with colorectal cancer (mean=0.97+/-0.14 ng/ml, ranged from 0.7 ng/ml to 1.37 ng/ml, n=50) were significantly greater than those in patients with adenomatous polyp (mean=0.73+/-0.06 ng/ml, ranged from 0.69 ng/ml to 0.83 ng/ml) (p<0.001). |
Gene Details

| Gene Type | protein coding |
|---|---|
| Gene Family | |
| Description | This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons (PMIDs: 12032546, 20937277).   | Chromosome | 17 |
| Location | 17p13.1 |
| Start | 7668402   |
| End | 7687550   |
| Strand | -   |
| Gene Sequence |    Download   Select all |
| Length | 19149   |
| OMIM ID | 191170    |
| HGNC ID | HGNC:11998    |
| Unigene ID | Hs.437460    |
| Ensembl ID | ENSG00000141510    |
| PharmGKB ID | -    |
mRNA Information
| mRNA ID | NM_001126112.2 |
|---|---|
| Exon | join(1..174,10932..11030,11148..11169,11279..11557, 12315..12498,12580..12692,13261..13370,13714..13850, 13943..14016,16836..16942,17861..19149)   | mRNA Sequence |    Download   Select all |
| Length | 2591   |
CDS Information
| Location | join(10957..11030,11148..11169,11279..11557,12315..12498, 12580..12692,13261..13370,13714..13850,13943..14016, 16836..16942,17861..17942) |
|---|---|
| CDS Sequence |    Download   Select all |
| CCDS ID | CCDS11118.1 |    
Protein Information
| Protein ID | NP_000537.3 |
|---|---|
| Protein Name | tumor protein p53 |
| Molecular Wt. (Da) | 43522 |
| Protein Sequence |    Download   Select all |
| Length | 393   |
| Uniprot ID | Q14623 |    
| Ensembl Protein ID | ENSP00000295731   |    
Post-translational Modification Information (Source : HPRD)
| Residue | Type | site |
|---|---|---|
| W | Proteolytic Cleavage | 23 |
| K | Ubiquitination | 351 |
| K | Ubiquitination | 357 |
| S | Phosphorylation | 366 |
| K | Ubiquitination | 373 |
| K | Ubiquitination | 386 |
| S | Phosphorylation | 392 |
| S | Phosphorylation | 15 |
| T | Phosphorylation | 55 |
| S | Phosphorylation | 371 |
| S | Phosphorylation | 378 |
| S | Phosphorylation | 392 |
| S | Phosphorylation | 6 |
| S | Phosphorylation | 9 |
| T | Phosphorylation | 18 |
| S | Phosphorylation | 15 |
| T | Phosphorylation | 18 |
| S | Phosphorylation | 20 |
| S | Phosphorylation | 33 |
| S | Phosphorylation | 37 |
| T | Phosphorylation | 81 |
| T | Phosphorylation | 18 |
| K | Acetylation | 305 |
| K | Acetylation | 370 |
| K | Acetylation | 372 |
| K | Acetylation | 373 |
| K | Acetylation | 381 |
| K | Acetylation | 382 |
| S | Phosphorylation | 20 |
| S | Phosphorylation | 15 |
| S | Phosphorylation | 20 |
| S | Phosphorylation | 37 |
| S | Dephosphorylation | 315 |
| S | Dephosphorylation | 315 |
| S | Phosphorylation | 33 |
| S | Phosphorylation | 46 |
| S | Phosphorylation | 15 |
| S | Phosphorylation | 20 |
| S | Phosphorylation | 33 |
| S | Phosphorylation | 37 |
| S | Phosphorylation | 46 |
| S | Phosphorylation | 9 |
| K | Acetylation | 320 |
| S | Phosphorylation | 15 |
| T | Phosphorylation | 18 |
| S | Phosphorylation | 20 |
| S | Phosphorylation | 37 |
| K | Deacylation | 382 |
| T | Proteolytic Cleavage | 18 |
| S | Proteolytic Cleavage | 20 |
| T | Phosphorylation | 18 |
| S | Phosphorylation | 392 |
| T | Phosphorylation | 18 |
| S | Phosphorylation | 315 |
| S | Phosphorylation | 392 |
| S | Phosphorylation | 315 |
| S | Phosphorylation | 33 |
| T | Phosphorylation | 155 |
| S | Phosphorylation | 33 |
| S | Phosphorylation | 315 |
| S | Phosphorylation | 392 |
| K | Acetylation | 292 |
| S | Phosphorylation | 15 |
| S | Dephosphorylation | 15 |
| K | Methylation | 372 |
| S | Phosphorylation | 37 |
| K | Deacetylation | 373 |
| K | Deacetylation | 382 |
| S | Phosphorylation | 33 |
| T | Phosphorylation | 81 |
| S | Phosphorylation | 315 |
| T | Dephosphorylation | 55 |
| K | Ubiquitination | 319 |
| K | Ubiquitination | 320 |
| K | Ubiquitination | 321 |
| K | Ubiquitination | 370 |
| K | Ubiquitination | 372 |
| K | Ubiquitination | 381 |
| K | Ubiquitination | 386 |
| K | Methylation | 370 |
| K | Neddylation | 370 |
| K | Neddylation | 372 |
| K | Neddylation | 373 |
| K | Neddylation | 381 |
| K | Neddylation | 382 |
| K | Neddylation | 386 |
| K | Neddylation | 321 |
| K | Neddylation | 320 |
| S | Phosphorylation | 99;- |
| S | Phosphorylation | 314 |
| K | Acetylation | 321 |
| S | Phosphorylation | 313 |
Enzyme Information
No matching records could be found.
PPi Information
(Click to view network : Source STRING)      View   
| Interactant Gene ID (Source: HPRD) | Gene Symbol | HPRD ID | Ref Seq ID | Technique | References |
|---|---|---|---|---|---|
| 25 |    ABL1 |    1809 |    NP_009297.2 |    in vitro;in vivo |    1   071   371   610   629   020    |
| 58 |    ACTA1 |    30 |    NP_001091.1 |    in vitro |    11821948    |
| 142 |    PARP1 |    1435 |    NP_001609.2 |    in vitro;in vivo |    95   656   081   289   852   300   000   000    |
| 328 |    APEX1 |    136 |    NP_542380.1 |    in vivo |    9119221    |
| 403 |    ARL3 |    5260 |    NP_004302.1 |    yeast 2-hybrid |    16169070    |
| 596 |    BCL2 |    1045 |    NP_000624.2 |    in vitro;in vivo |    12667443    |
| 672 |    BRCA1 |    218 |    NP_009231.2 |    in vitro;in vivo |    9   482   880   992   694   210   000   000   000   000   000   000   000    |
| 695 |    BTK |    2248 |    NP_000052.1 |    in vitro |    15355990    |
| 890 |    CCNA2 |    453 |    NP_001228.1 |    in vitro |    10884347    |
| 959 |    CD40LG |    2311 |    NP_000065.1 |    in vivo |    12011072    |
| 983 |    CDK1 |    302 |    NP_001777.1 |    in vitro;in vivo |    11327730    |
| 995 |    CDC25C |    1146 |    NP_001781.2 |    in vitro;in vivo |    1   085   303   816   753   140    |
| 1031 |    CDKN2C |    4534 |    NP_001253.1 |    yeast 2-hybrid |    16169070    |
| 1380 |    CR2 |    399 |    NP_001006659.1 |    in vitro |    7753047    |
| 1856 |    DVL2 |    3690 |    NP_004413.1 |    yeast 2-hybrid |    1   618   951   416   713   560    |
| 1869 |    E2F1 |    1806 |    NP_005216.1 |    in vitro;in vivo |    11739724    |
| 1938 |    EEF2 |    561 |    NP_001952.1 |    in vivo |    12891704    |
| 1958 |    EGR1 |    549 |    NP_001955.1 |    in vitro;in vivo |    11251186    |
| 2042 |    EPHA3 |    1555 |    NP_005224.2 |    in vitro |    15355990    |
| 2071 |    ERCC3 |    593 |    NP_000113.1 |    in vitro |    7663514    |
| 2074 |    ERCC6 |    596 |    NP_000115.1 |    in vitro;in vivo |    10882116    |
| 2079 |    ERH |    9026 |    NP_004441.1 |    yeast 2-hybrid |    16169070    |
| 2099 |    ESR1 |    589 |    NP_000116.2 |    in vitro |    10766163    |
| 2547 |    XRCC6 |    1071 |    NP_001460.1 |    in vivo |    15782130    |
| 2908 |    NR3C1 |    679 |    NP_001019265.1 |    in vitro;in vivo |    11080152    |
| 2965 |    GTF2H1 |    1807 |    NP_005307.1 |    in vitro |    7935417    |
| 3064 |    HTT |    883 |    NP_002102.4 |    in vitro;in vivo |    10823891    |
| 3065 |    HDAC1 |    3143 |    NP_004955.2 |    in vitro;in vivo |    1   077   747   716   959   610    |
| 3066 |    HDAC2 |    5521 |    NP_001518.2 |    in vitro;in vivo |    10777477    |
| 3146 |    HMGB1 |    1228 |    NP_002119.1 |    in vitro;in vivo |    94   720   151   110   665   400   000   000    |
| 3148 |    HMGB2 |    1229 |    NP_002120.1 |    in vitro |    11748232    |
| 3164 |    NR4A1 |    744 |    NP_002126.2 |    in vitro;in vivo;yeast 2-hybrid |    17139261    |
| 3303 |    HSPA1A |    774 |    NP_005336.3 |    in vivo |    7811761    |
| 3315 |    HSPB1 |    9076 |    NP_001531.1 |    yeast 2-hybrid |    16169070    |
| 3320 |    HSP90AA1 |    777 |    NP_001017963.2 |    in vivo |    1   150   708   812   427   750    |
| 3428 |    IFI16 |    969 |    NP_005522.2 |    in vivo |    11146555    |
| 3910 |    LAMA4 |    2532 |    NP_001098676.1 |    yeast 2-hybrid |    16169070    |
| 4087 |    SMAD2 |    3221 |    NP_005892.1 |    in vitro;in vivo |    12732139    |
| 4088 |    SMAD3 |    4380 |    NP_005893.1 |    in vitro;in vivo |    12732139    |
| 4193 |    MDM2 |    1272 |    NP_002383.2 |    in vitro;in vivo;yeast 2-hybrid |    1   643   219   612   867   030   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000   000    |
| 4691 |    NCL |    1245 |    NP_005372.2 |    in vitro;in vivo |    12138209    |
| 4792 |    NFKBIA |    1235 |    NP_065390.1 |    in vivo;yeast 2-hybrid |    11799106    |
| 4800 |    NFYA |    1793 |    NP_002496.1 |    in vivo |    16959611    |
| 4801 |    NFYB |    1794 |    NP_006157.1 |    in vivo |    16959611    |
| 4904 |    YBX1 |    1095 |    NP_004550.2 |    in vitro;in vivo |    1   117   533   311   973   330    |
| 5050 |    PAFAH1B3 |    4354 |    NP_002564.1 |    yeast 2-hybrid |    16169070    |
| 5245 |    PHB |    1454 |    NP_002625.1 |    in vitro;in vivo |    14500729    |
| 5272 |    SERPINB9 |    3480 |    NP_004146.1 |    yeast 2-hybrid |    16169070    |
| 5347 |    PLK1 |    3652 |    NP_005021.2 |    in vivo;yeast 2-hybrid |    16753148    |
| 5371 |    PML |    23 |    NP_150241.2 |    in vitro;in vivo |    117   048   531   102   566   000   000   000    |
| 5499 |    PPP1CA |    15942 |    NP_001008709.1 |    yeast 2-hybrid |    15231748    |
| 5521 |    PPP2R2B |    5059 |    NP_858062.1 |    in vivo |    17245430    |
| 5717 |    PSMD11 |    5119 |    NP_002806.2 |    yeast 2-hybrid |    16169070    |
| 5888 |    RAD51 |    1557 |    NP_597994.3 |    in vitro;in vivo |    93   805   108   617   246    |
| 6117 |    RPA1 |    1565 |    NP_002936.1 |    in vitro;in vivo |    1   175   142   783   615   420   000   000   000   000   000    |
| 6241 |    RRM2 |    1587 |    NP_001025.1 |    in vivo |    12615712    |
| 6275 |    S100A4 |    15914 |    NP_002952.1 |    in vitro |    11   527   429   151   160   900   000   000   000   000   000    |
| 6285 |    S100B |    1505 |    NP_006263.1 |    in vitro |    1   152   742   910   876   240    |
| 6303 |    SAT1 |    2431 |    NP_002961.1 |    yeast 2-hybrid |    16169070    |
| 6362 |    CCL18 |    4784 |    NP_002979.1 |    yeast 2-hybrid |    16169070    |
| 6602 |    SMARCD1 |    3438 |    NP_003067.3 |    yeast 2-hybrid |    18303029    |
| 6667 |    SP1 |    1796 |    NP_612482.2 |    in vitro;in vivo |    9   492   043   157   903   100   000   000   000   000   000    |
| 6670 |    SP3 |    3483 |    NP_003102.1 |    in vitro;in vivo |    15790310    |
| 6753 |    SSTR3 |    1675 |    NP_001042.1 |    in vivo |    8961277    |
| 6783 |    SULT1E1 |    8966 |    NP_005411.1 |    yeast 2-hybrid |    16169070    |
| 6811 |    STX5 |    4426 |    NP_003155.2 |    yeast 2-hybrid |    16169070    |
| 7006 |    TEC |    2786 |    NP_003206.2 |    in vitro |    15355990    |
| 7020 |    TFAP2A |    128 |    NP_003211.1 |    in vitro;in vivo;yeast 2-hybrid |    12226108    |
| 7027 |    TFDP1 |    1792 |    NP_009042.1 |    in vitro;in vivo |    8816502    |
| 7150 |    TOP1 |    535 |    NP_003277.1 |    in vitro;in vivo |    104   686   128   639   538    |
| 7153 |    TOP2A |    536 |    NP_001058.2 |    in vitro;in vivo |    10666337    |
| 7155 |    TOP2B |    537 |    NP_001059.2 |    in vitro;in vivo |    10666337    |
| 7314 |    UBB |    6771 |    NP_061828.1 |    in vitro;in vivo |    12421820    |
| 7572 |    ZNF24 |    1921 |    NP_008896.2 |    yeast 2-hybrid |    16169070    |
| 8841 |    HDAC3 |    8950 |    NP_003874.2 |    in vitro;in vivo |    10777477    |
| 8894 |    EIF2S2 |    4882 |    NP_003899.2 |    yeast 2-hybrid |    16169070    |
| 9522 |    SCAMP1 |    6072 |    NP_004857.4 |    yeast 2-hybrid |    16713569    |
| 9587 |    MAD2L1BP |    10065 |    NP_001003690.1 |    yeast 2-hybrid |    16169070    |
| 10063 |    COX17 |    5314 |    NP_005685.1 |    yeast 2-hybrid |    16169070    |
| 10200 |    MPHOSPH6 |    16111 |    NP_005783.2 |    yeast 2-hybrid |    16169070    |
| 10301 |    DLEU1 |    16150 |    NP_005878.1 |    yeast 2-hybrid |    16169070    |
| 10425 |    ARIH2 |    9286 |    NP_006312.1 |    yeast 2-hybrid |    16169070    |
| 10524 |    KAT5 |    3245 |    NP_874369.1 |    in vivo |    16601686    |
| 10571 |    - |    10240 |    NP_006771.1 |    yeast 2-hybrid |    16169070    |
| 11200 |    CHEK2 |    5084 |    NP_001005735.1 |    in vitro |    17157788    |
| 22948 |    CCT5 |    6468 |    NP_036205.1 |    yeast 2-hybrid |    16169070    |
| 29903 |    CCDC106 |    9995 |    NP_037433.2 |    yeast 2-hybrid |    16169070    |
| 53826 |    FXYD6 |    9456 |    AAQ89335.1 |    yeast 2-hybrid |    16169070    |
| 54819 |    ZCCHC10 |    15699 |    NP_060135.1 |    yeast 2-hybrid |    16169070    |
| 55339 |    WDR33 |    11680 |    NP_060853.3 |    yeast 2-hybrid |    16169070    |
| 55643 |    BTBD2 |    12252 |    NP_060267.2 |    yeast 2-hybrid |    16169070    |
| 56144 |    PCDHA4 |    7322 |    NP_061730.1 |    yeast 2-hybrid |    16169070    |
| 65990 |    FAM173A |    14500 |    NP_076422.1 |    yeast 2-hybrid |    16169070    |
| 80204 |    FBXO11 |    6985 |    NP_079409.3 |    in vitro;in vivo |    17098746    |
| 199745 |    THAP8 |    15501 |    NP_689871.1 |    yeast 2-hybrid |    16169070    |
| 286514 |    MAGEB18 |    6647 |    NP_775970.1 |    yeast 2-hybrid |    1   618   951   416   713   560    |
Pathway Information
| Pathway Name | Pathway ID |
|---|---|
| Amyotrophic lateral sclerosis (ALS) |    hsa05014 |    
| Apoptosis |    hsa04210 |    
| Basal cell carcinoma |    hsa05217 |    
| Bladder cancer |    hsa05219 |    
| Cell cycle |    hsa04110 |    
| Central carbon metabolism in cancer |    hsa05230 |    
| Chronic myeloid leukemia |    hsa05220 |    
| Colorectal cancer |    hsa05210 |    
| Endometrial cancer |    hsa05213 |    
| Epstein-Barr virus infection |    hsa05169 |    
| Glioma |    hsa05214 |    
| Hepatitis B |    hsa05161 |    
| Hepatitis C |    hsa05160 |    
| Herpes simplex infection |    hsa05168 |    
| HTLV-I infection |    hsa05166 |    
| Huntington's disease |    hsa05016 |    
| Longevity regulating pathway - mammal |    hsa04211 |    
| MAPK signaling pathway |    hsa04010 |    
| Measles |    hsa05162 |    
| Melanoma |    hsa05218 |    
| MicroRNAs in cancer |    hsa05206 |    
| Neurotrophin signaling pathway |    hsa04722 |    
| Non-small cell lung cancer |    hsa05223 |    
| p53 signaling pathway |    hsa04115 |    
| Pancreatic cancer |    hsa05212 |    
| Pathways in cancer |    hsa05200 |    
| PI3K-Akt signaling pathway |    hsa04151 |    
| Prostate cancer |    hsa05215 |    
| Proteoglycans in cancer |    hsa05205 |    
| Small cell lung cancer |    hsa05222 |    
| Sphingolipid signaling pathway |    hsa04071 |    
| Thyroid cancer |    hsa05216 |    
| Thyroid hormone signaling pathway |    hsa04919 |    
| Transcriptional misregulation in cancer |    hsa05202 |    
| Viral carcinogenesis |    hsa05203 |    
| Wnt signaling pathway |    hsa04310 |    
Structure Information
No matching records could be found.
Domain Information
| ID | Location | Description |
|---|---|---|
| cd08367 | 109-288  | P53 |
| cl14608 | 109-288  | P53 superfamily |
| pfam00870 | 95-289  | P53 |
| pfam07710 | 324-359  | P53_tetramer |
| cl06653 | 324-359  | P53_tetramer superfamily |
| pfam08563 | 29-May  | P53_TAD |
| cl07246 | 29-May  | P53_TAD superfamily |
Ontology Information
| HPRD ID | 988 |    
|---|---|
| Molecular Class | Transcription factor |
| Molecular Function | Cytokine activity (GO:0005125) |
| Biological Process | Immune response (GO:0006955)   |
Drug Information
| Uniprot ID | DrugBank ID | Name | Type |
|---|---|---|---|
| P04637 | DB00945 | Acetylsalicylic acid | SmallMoleculeDrug |
External Links
| ArrayExpress | GO |    
|---|---|
| ICGC | GO |    
| Cancer3D | GO |    
| COSMIC | GO |    
| NCG | GO |    
| TSGene | GO |    
| Tumor Gene Family of Databases | GO |    
| CCDB | GO |    
| G2SBC | GO |    
| Osteosarcoma Database | GO |    
| RCDB | GO |    
